Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 33.74B | 28.47B | 6.44B | 36.68B | 21.90B |
Gross Profit | 33.74B | 28.47B | 6.44B | 36.68B | 21.90B |
EBITDA | 1.47B | 1.28B | 1.51B | 2.49B | 914.10M |
Net Income | 608.16M | 587.18M | 750.97M | 1.39B | 388.63M |
Balance Sheet | |||||
Total Assets | 219.64B | 204.86B | 196.90B | 204.16B | 181.92B |
Cash, Cash Equivalents and Short-Term Investments | 46.09B | 41.00B | 38.79B | 37.79B | 29.44B |
Total Debt | 5.99B | 5.97B | 7.19B | 5.42B | 4.97B |
Total Liabilities | 210.09B | 196.26B | 188.80B | 195.59B | 175.04B |
Stockholders Equity | 9.54B | 8.59B | 8.09B | 8.56B | 6.88B |
Cash Flow | |||||
Free Cash Flow | 3.05B | 2.15B | -3.11B | 6.88B | -5.26B |
Operating Cash Flow | 3.38B | 2.44B | -2.85B | 7.12B | -5.07B |
Investing Cash Flow | -353.88M | -284.03M | -254.66M | -245.25M | -181.84M |
Financing Cash Flow | 630.00M | -1.35B | 1.18B | 773.24M | 968.91M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | $20.08B | 16.31 | 12.96% | 5.22% | -10.79% | 67.20% | |
72 Outperform | 16.63B | 13.53 | 3.63% | -2.35% | 80.26% | ||
71 Outperform | 14.88B | 17.24 | 15.69% | 4.36% | 8.25% | 25.93% | |
67 Neutral | 3.28B | 11.02 | 6.70% | 25.90% | 68.30% | ||
67 Neutral | 10.12B | 13.20 | 0.61% | -16.50% | 29.61% | ||
62 Neutral | 12.35B | 11.34 | 1.62% | ― | ― |
Migdal Insurance Company is facing scrutiny from the Commissioner of Capital Market, Insurance and Savings due to high turnover in its board leadership, as evidenced by the recent resignation of Chairman Prof. Amir Barnea after a short tenure. The Commissioner has raised concerns about the potential mismanagement of the company, emphasizing the need for independent and stable leadership decisions, and is considering using legal powers to enforce governance standards at Migdal Insurance.
Migdal Insur. announced that the Tel Aviv District Court has dismissed a class action approval request against its subsidiary, Migdal Insurance Company Ltd., and four other respondents. The lawsuit involved alleged discrimination in travel insurance policies for not covering mental illnesses. The dismissal was due to the non-appointment of a representative counsel by the applicant, as previously required by the court, and was resolved without an order for expenses.
Migdal Insurance has issued a corrective report related to a previous securities register report, indicating an error due to human oversight. The primary correction involved deducting private shareholders’ securities, which were transferred for registration on the Tel Aviv Stock Exchange. This update highlights a transfer between shareholders, affecting securities ownership without altering the total number of securities. Such adjustments are critical for maintaining accurate records and transparency in shareholder information, impacting investor trust and regulatory compliance.
Migdal Insurance announced a change in its capital structure involving a transfer of securities between shareholders. This adjustment, which did not alter the total quantity of securities, was executed without stock exchange clearing. The changes reflect an update to the corporation’s security registry, affecting the balance of regular shares held by the Company for Registration of the Stock Exchange in Tel Aviv Ltd. This move is part of ongoing securities management and aligns with regulatory compliance as outlined by the Securities Regulations.
Migdal Insurance Company Ltd. has announced that its Chairman of the Board of Directors is ending his tenure. This development could impact the company’s governance and strategic direction, with potential implications for stakeholders in terms of leadership transition and future company policies.